Combined screening for Chlamydia trachomatis and squamous intra-epithelial lesions using a single liquid-based cervical sample

Human Reproduction

Volumn 16, Issue 10, 2001, Pages 2206-2210

  Anguenot, J L ^a   De Marval, F ^a   Vassilakos, P ^a   Auckenthaler, R ^a   Ibecheole V ^a   Campana, A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cervical screening; Chlamydia trachomatis; DNA amplification techniques; Liquid based cervical sample; Squamous intra epithelial lesion

Indexed keywords

PRESERVATION SOLUTION;

AGE; ARTICLE; BACTERIUM DETECTION; BIOMEDICAL TECHNOLOGY ASSESSMENT; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL PROTOCOL; CLINICAL TRIAL; DEVICE; EVALUATION; FEASIBILITY STUDY; FEMALE; GENE AMPLIFICATION; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INFLAMMATION; INTERMETHOD COMPARISON; LIGASE CHAIN REACTION; LIQUID; MAJOR CLINICAL STUDY; MASS SCREENING; METHODOLOGY; NONHUMAN; POPULATION RISK; PREVALENCE; SAMPLE; SCREENING TEST; STATISTICAL ANALYSIS; SWITZERLAND; TISSUE PRESERVATION; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM; VAGINA SMEAR;

EID: 0034784472     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.10.2206     Document Type: Article

References (25)

1. Detection of Chlamydia trachomatis in pregnant women by the Papanicolaou technique, enzyme immunoassay and polymerase chain reaction
2. Sexually transmitted agents and cervical neoplasia in Colombia and Spain
3. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: Ecological analysis
4. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women
5. Screening women for chlamydia trachomatis in family planning clinics: The cost-effectiveness of DNA amplification assays
6. Reproductive and infectious risk factors for invasive cervical cancer in Taiwan
7. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics
8. Epidemiology of ectopic pregnancy during a 28 year period and the role of pelvic inflammatory disease
9. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer
10. A cohort study of the risk of cervical intra-epithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
11. Comparison of conventional PAP smears with thin layer specimen (liquid-based PAP test) and correlation with cytopathological finding with HPV status using the hybrid capture system
12. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop
13. Is screening for Chlamydia trachomatis infection cost effective?
14. Demonstration of Chlamydia trachomatis in Papanicolaou-stained gynecological smears
15. Why do patients default from follow-up at a genitourinary clinic?: A multivariate analysis
16. Chlamydia trachomatis and cervical neoplasia
17. Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix
18. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection
19. Acceptable values of kappa for comparison of two groups
20. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan
21. Human papillomavirus (HPV) DNA assay as an adjunct to liquid-based Pap test in the diagnostic triage of women with an abnormal Pap smear
22. CytoRich liquid-based cervical cytologic test. Screening results in a routine cytopathology service
23. Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories
24. Taux de participation au dépistage du cancer du col utérin d'après l'Enquête Suisse de santé conduite en 1997
25. Laboratory diagnosis of Chlamydia trachomatis infections